A prospective, population-based cohort study with a two-year follow-up revealed that an increasing CRP trajectory pattern was associated with a heightened risk of various cancers, including lung, breast, leukemia, bladder, stomach, colorectal, liver, gallbladder, and extrahepatic bile duct cancer. Here, CRP is linked to cancer.